Organizational identity, organizational capabilities, and the evolution of the multinational corporation : JTech's transmission systems business in the US

Thesis (Ph. D.)--Massachusetts Institute of Technology, Sloan School of Management, 2007."June 2007."Includes bibliographical references (v. 2, leaves 259-267).When a multinational corporation (MNC) internationalizes by establishing a new subsidiary, the subsidiary's evolution depends upon its acceptance within its host country environment, by its home country headquarters, by other subsidiaries, and by all other stakeholders, including employees, suppliers, customers, complementary innovators, product market critics and analysts. To be accepted, the subsidiary organization has to have a legitimate form with some combination of properties - such as activities, features, and boundaries - that make it recognizable and understandable as a meaningful social unit. In short, as a social object, the subsidiary has to have an identity that conforms to a recognized and accepted type, so that it is evaluated positively as belonging to a legitimate category of organizations. Yet, if value creation simultaneously depends upon a subsidiary developing organizational capabilities, how does its identity shape the development of those capabilities? How do the capabilities in turn alter the subsidiary's identity? How does the identity-capability relationship influence the subsidiary's strategy, and how do the organizational structures put in place to cope with these changes affect the organization's identity and legitimacy? I explore these issues by analyzing the case of the evolution of a US subsidiary of a Japanese high technology MNC, which had responsibility for activities related to the development and sale of transmission equipment into the US, over a fifteen year period ending in 2000. I find that organizational members constructed an identity for their organization through which they enacted their environment, organizational capabilities, strategy, and structure.(cont.) These, in turn, recursively interacted with the organizational identity in complex ways, either reinforcing the salient organizational identity or stressing it, resulting in identity work through which organizational members sought to reconstruct a new and legitimate organizational identity. Understanding the identity of a subsidiary is necessary in efforts to improve the effectiveness of managing across borders. As a corollary, management practices designed to improve collaboration, such as facilitating the transfer of more complex information, or that aim to deepen understanding among collaborating units of an MNC, such as increasing personnel transfers, may actually undermine cross-border knowledge development through their negative effect on organizational identity.by Christopher J. Voisey.Ph.D

Enhancing Discovery of Genetic Variants for Posttraumatic Stress Disorder Through Integration of Quantitative Phenotypes and Trauma Exposure Information

Funding Information: This work was supported by the National Institute of Mental Health / U.S. Army Medical Research and Development Command (Grant No. R01MH106595 [to CMN, IL, MBS, KJRe, and KCK], National Institutes of Health (Grant No. 5U01MH109539 to the Psychiatric Genomics Consortium ), and Brain & Behavior Research Foundation (Young Investigator Grant [to KWC]). Genotyping of samples was provided in part through the Stanley Center for Psychiatric Genetics at the Broad Institute supported by Cohen Veterans Bioscience . Statistical analyses were carried out on the LISA/Genetic Cluster Computer ( https://userinfo.surfsara.nl/systems/lisa ) hosted by SURFsara. This research has been conducted using the UK Biobank resource (Application No. 41209). This work would have not been possible without the financial support provided by Cohen Veterans Bioscience, the Stanley Center for Psychiatric Genetics at the Broad Institute, and One Mind. Funding Information: MBS has in the past 3 years received consulting income from Actelion, Acadia Pharmaceuticals, Aptinyx, Bionomics, BioXcel Therapeutics, Clexio, EmpowerPharm, GW Pharmaceuticals, Janssen, Jazz Pharmaceuticals, and Roche/Genentech and has stock options in Oxeia Biopharmaceuticals and Epivario. In the past 3 years, NPD has held a part-time paid position at Cohen Veterans Bioscience, has been a consultant for Sunovion Pharmaceuticals, and is on the scientific advisory board for Sentio Solutions for unrelated work. In the past 3 years, KJRe has been a consultant for Datastat, Inc., RallyPoint Networks, Inc., Sage Pharmaceuticals, and Takeda. JLM-K has received funding and a speaking fee from COMPASS Pathways. MU has been a consultant for System Analytic. HRK is a member of the Dicerna scientific advisory board and a member of the American Society of Clinical Psychopharmacology Alcohol Clinical Trials Initiative, which during the past 3 years was supported by Alkermes, Amygdala Neurosciences, Arbor Pharmaceuticals, Dicerna, Ethypharm, Indivior, Lundbeck, Mitsubishi, and Otsuka. HRK and JG are named as inventors on Patent Cooperative Treaty patent application number 15/878,640, entitled “Genotype-guided dosing of opioid agonists,” filed January 24, 2018. RP and JG are paid for their editorial work on the journal Complex Psychiatry. OAA is a consultant to HealthLytix. All other authors report no biomedical financial interests or potential conflicts of interest. Funding Information: This work was supported by the National Institute of Mental Health/ U.S. Army Medical Research and Development Command (Grant No. R01MH106595 [to CMN, IL, MBS, KJRe, and KCK], National Institutes of Health (Grant No. 5U01MH109539 to the Psychiatric Genomics Consortium), and Brain & Behavior Research Foundation (Young Investigator Grant [to KWC]). Genotyping of samples was provided in part through the Stanley Center for Psychiatric Genetics at the Broad Institute supported by Cohen Veterans Bioscience. Statistical analyses were carried out on the LISA/Genetic Cluster Computer (https://userinfo.surfsara.nl/systems/lisa) hosted by SURFsara. This research has been conducted using the UK Biobank resource (Application No. 41209). This work would have not been possible without the financial support provided by Cohen Veterans Bioscience, the Stanley Center for Psychiatric Genetics at the Broad Institute, and One Mind. This material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting true views of the U.S. Department of the Army or the Department of Defense. We thank the investigators who comprise the PGC-PTSD working group and especially the more than 206,000 research participants worldwide who shared their life experiences and biological samples with PGC-PTSD investigators. We thank Mark Zervas for his critical input. Full acknowledgments are in Supplement 1. MBS has in the past 3 years received consulting income from Actelion, Acadia Pharmaceuticals, Aptinyx, Bionomics, BioXcel Therapeutics, Clexio, EmpowerPharm, GW Pharmaceuticals, Janssen, Jazz Pharmaceuticals, and Roche/Genentech and has stock options in Oxeia Biopharmaceuticals and Epivario. In the past 3 years, NPD has held a part-time paid position at Cohen Veterans Bioscience, has been a consultant for Sunovion Pharmaceuticals, and is on the scientific advisory board for Sentio Solutions for unrelated work. In the past 3 years, KJRe has been a consultant for Datastat, Inc. RallyPoint Networks, Inc. Sage Pharmaceuticals, and Takeda. JLM-K has received funding and a speaking fee from COMPASS Pathways. MU has been a consultant for System Analytic. HRK is a member of the Dicerna scientific advisory board and a member of the American Society of Clinical Psychopharmacology Alcohol Clinical Trials Initiative, which during the past 3 years was supported by Alkermes, Amygdala Neurosciences, Arbor Pharmaceuticals, Dicerna, Ethypharm, Indivior, Lundbeck, Mitsubishi, and Otsuka. HRK and JG are named as inventors on Patent Cooperative Treaty patent application number 15/878,640, entitled ?Genotype-guided dosing of opioid agonists,? filed January 24, 2018. RP and JG are paid for their editorial work on the journal Complex Psychiatry. OAA is a consultant to HealthLytix. All other authors report no biomedical financial interests or potential conflicts of interest. Publisher Copyright: © 2021 Society of Biological PsychiatryBackground: Posttraumatic stress disorder (PTSD) is heritable and a potential consequence of exposure to traumatic stress. Evidence suggests that a quantitative approach to PTSD phenotype measurement and incorporation of lifetime trauma exposure (LTE) information could enhance the discovery power of PTSD genome-wide association studies (GWASs). Methods: A GWAS on PTSD symptoms was performed in 51 cohorts followed by a fixed-effects meta-analysis (N = 182,199 European ancestry participants). A GWAS of LTE burden was performed in the UK Biobank cohort (N = 132,988). Genetic correlations were evaluated with linkage disequilibrium score regression. Multivariate analysis was performed using Multi-Trait Analysis of GWAS. Functional mapping and annotation of leading loci was performed with FUMA. Replication was evaluated using the Million Veteran Program GWAS of PTSD total symptoms. Results: GWASs of PTSD symptoms and LTE burden identified 5 and 6 independent genome-wide significant loci, respectively. There was a 72% genetic correlation between PTSD and LTE. PTSD and LTE showed largely similar patterns of genetic correlation with other traits, albeit with some distinctions. Adjusting PTSD for LTE reduced PTSD heritability by 31%. Multivariate analysis of PTSD and LTE increased the effective sample size of the PTSD GWAS by 20% and identified 4 additional loci. Four of these 9 PTSD loci were independently replicated in the Million Veteran Program. Conclusions: Through using a quantitative trait measure of PTSD, we identified novel risk loci not previously identified using prior case-control analyses. PTSD and LTE have a high genetic overlap that can be leveraged to increase discovery power through multivariate methods.publishersversionpublishe

Tracing the fluid evolution of the Kiruna iron oxide apatite deposits using zircon, monazite, and whole rock trace elements and isotopic studies

The ore genesis of the Paleoproterozoic iron oxide apatite deposits in the vicinity of Kiruna in northern Sweden is poorly understood, despite a century-long mining history and 2500 Mt of iron ore with grades of 30 to 70 wt% Fe produced in the region to date. Zircon grains from the ore, recently dated at ca. 1874 Ma, show very different appearances compared to zircon from surrounding host rocks (ca. 1880 Ma) and related intrusions (ca. 1880 and ca. 1874 Ma), particularly an inclusion-rich rim. In contrast, zircon from the host rocks, and a proximal granite intrusion, exhibit typical igneous growth zoning. Electron microprobe results show near stoichiometric composition for Zr, Si, and Hf in the host rock zircon grains. The ore zircon crystals have low analytical totals with significant concentrations of Ca, Fe, Y, and P and infrared spectroscopy showed several weight percent of water. These ore zircon grains further show Fe-rich inclusions, zones and/or veins in elemental X-ray maps, and light rare earth elements (LREE) enrichment. Transmission electron microscopy (TEM) shows that the LREE are not due to micro- or nano-inclusions in the zircon, but are likely hosted as LREE oxides in amorphous regions of the grains. Based on these characteristics, the rims on ore zircon grains are interpreted to be of hydrothermal origin. Uranium-Pb in monazite from the ore, measured by SIMS, suggests a secondary event influencing the area at ca. 1624 Ma, a period of known geologic activity in Fennoscandia. Electron microprobe X-ray mapping of these monazite grains shows no zoning and relatively low U and Th concentrations. Stark contrasts are visible between the ore (depleted mantle influence) and host rocks (crustal influence) in the whole rock Lu-Hf and Sm-Nd data. The depleted mantle signature of the ore could be related to the Kiruna greenstone group as a potential source region for the iron. The Sm-Nd isotopic composition of monazite from the ore shows a crustal influence, and indicates that the younger event has not disturbed the whole rock Sm-Nd signature of the ore. The hydrothermal nature of the ore zircon grains and the isotopic signatures point to a hydrothermal influence on the ore formation, with a high temperature magmatic fluid related to the intrusions as most likely heat and fluid source

Tracing the fluid evolution of the Kiruna iron oxide apatite deposits using zircon, monazite, and whole rock trace elements and isotopic studies

The ore genesis of the Paleoproterozoic iron oxide apatite deposits in the vicinity of Kiruna in northern Sweden is poorly understood, despite a century-long mining history and 2500 Mt of iron ore with grades of 30 to 70 wt% Fe produced in the region to date. Zircon grains from the ore, recently dated at ca. 1874 Ma, show very different appearances compared to zircon from surrounding host rocks (ca. 1880 Ma) and related intrusions (ca. 1880 and ca. 1874 Ma), particularly an inclusion-rich rim. In contrast, zircon from the host rocks, and a proximal granite intrusion, exhibit typical igneous growth zoning. Electron microprobe results show near stoichiometric composition for Zr, Si, and Hf in the host rock zircon grains. The ore zircon crystals have low analytical totals with significant concentrations of Ca, Fe, Y, and P and infrared spectroscopy showed several weight percent of water. These ore zircon grains further show Fe-rich inclusions, zones and/or veins in elemental X-ray maps, and light rare earth elements (LREE) enrichment. Transmission electron microscopy (TEM) shows that the LREE are not due to micro- or nano-inclusions in the zircon, but are likely hosted as LREE oxides in amorphous regions of the grains. Based on these characteristics, the rims on ore zircon grains are interpreted to be of hydrothermal origin. Uranium-Pb in monazite from the ore, measured by SIMS, suggests a secondary event influencing the area at ca. 1624 Ma, a period of known geologic activity in Fennoscandia. Electron microprobe X-ray mapping of these monazite grains shows no zoning and relatively low U and Th concentrations. Stark contrasts are visible between the ore (depleted mantle influence) and host rocks (crustal influence) in the whole rock Lu-Hf and Sm-Nd data. The depleted mantle signature of the ore could be related to the Kiruna greenstone group as a potential source region for the iron. The Sm-Nd isotopic composition of monazite from the ore shows a crustal influence, and indicates that the younger event has not disturbed the whole rock Sm-Nd signature of the ore. The hydrothermal nature of the ore zircon grains and the isotopic signatures point to a hydrothermal influence on the ore formation, with a high temperature magmatic fluid related to the intrusions as most likely heat and fluid source

Factor structure of posttraumatic stress disorder (PTSD) in Australian Vietnam Veterans: Confirmatory factor analysis of the Clinician-Administered PTSD Scale for DSM–5

Introduction: The Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM–5) brought a change to the symptom clusters of posttraumatic stress disorder (PTSD). In line with the DSM–5 changes, an updated version of the Clinician-Administered PTSD Scale (CAPS–5) was released. The CAPS–5 is considered to be the gold-standard measure of PTSD; however, examinations of the psychometric properties and optimal factor structure of this scale are underrepresented in PTSD studies. Methods: This study used confirmatory factor analysis (CFA) to assess the factor structure of the CAPS–5 using a sample of 267 male Australian Vietnam Veterans. Models drawn from the PTSD CFA literature were used to test the underlying dimensions of PTSD: the four-factor DSM–5 model, six-factor externalizing behaviour and anhedonia models, and seven-factor hybrid model. Results: The results found that the DSM–5 model showed slightly less than adequate fit (comparative fit index [CFI] = 0.90, Tucker–Lewis index [TLI] = 0.88, root mean square error of approximation [RMSEA] = 0.064), however, other models showed acceptable fit. The anhedonia model provided a significantly better fit than the other models (CFI = 0.92, TLI = 0.90, RMSEA = 0.059). Discussion: Overall, the results supported the anhedonia model. This result may indicate that the underlying dimensions of PTSD in Australian Vietnam Veterans may best be represented by six distinct factors.</p

Resilience and psychopathology in trauma-exposed Australian Veterans: An exploratory factor analysis of the Connor-Davidson Resilience Scale

Introduction: Resilience refers to the ability to cope with and adapt to significant adversity. It is a vital psychological construct among military personnel, who are often exposed to multiple stressors. The Connor-Davidson Resilience Scale (CD-RISC) is one of the most widely used resilience scales; however, the factor structure is inconsistent when used with military populations and has not been assessed in an Australian military population. The aim of this study was to explore the factor structure of the CD-RISC and investigate the relationship between resilience and psychopathology in an Australian Veteran sample. Methods: Australian trauma-exposed Veterans (N = 265) completed the CD-RISC, along with the Clinician-Administered PTSD Scale for DSM-5 and the Depression, Anxiety and Stress Scale-21. Exploratory factor analysis methods were used to explore the factor structure of the CD-RISC. Correlations and regression analyses were performed to investigate the relationship between resilience and psychological health. Results: A four-factor solution was proposed after removal of four poorly performing items. These factors were Self-Efficacy, Adaptability, Determination, and Tolerance of Negative Affect. The revised 21-item CD-RISC demonstrated excellent internal consistency, and regression analyses revealed a negative relationship between resilience factor scores and psychopathology. Compared with other resilience factors, Self-Efficacy contributed the largest proportion of unique variance to posttraumatic stress disorder, depression, and stress symptoms. Discussion: These findings provide preliminary support for the use of the revised 21-item CD-RISC as a reliable and valid measure of resilience in an Australian Veteran population, and highlight the potential benefit of cultivating self-efficacy in targeted resilience-building programs.</p

Sleep disturbances in australian Vietnam veterans with and without posttraumatic stress disorder

Study Objectives: Posttraumatic stress disorder (PTSD) is a condition that may develop after a traumatic event, particularly combat-related trauma. Although sleep disturbance is a hallmark of PTSD, the prevalence of sleep disturbances in Australian veterans with PTSD remains uncertain. This study aimed to subjectively compare the prevalence of sleep disturbances in Australian Vietnam veterans with and without PTSD. Methods: A cross-sectional cohort study compared trauma-exposed Australian Vietnam veterans with and without PTSD. PTSD diagnosis was confrmed using the Clinician Administered PTSD Scale for DSM-5. Sleep information was evaluated using supervised structured questionnaires, including Epworth Sleepiness Scale (ESS) and Berlin and Mayo Questionnaires. Results: Two hundred fourteen male Vietnam veterans (108 with PTSD) were included. Participants with PTSD had higher body mass index (30.3 versus 29 kg/m; P < .05), higher ESS score (9.2 versus 7.6; P < .05), and increased alcohol or medication use to assist with sleep (19% versus 6%; P < .01; and 44% versus 14%; P < .01). Those with PTSD were less likely to sleep well (32% versus 72%; P < .01) and reported higher rates of restless legs (45% versus 25%; P < .01), nightmares (91% versus 29%; P < .01), nocturnal screaming (73% versus 18%; P < .01), sleep terrors (61% versus 13%; P < .01) and dream enactment (78% versus 11.8%; P < .01). The PTSD group had higher rates of diagnosed OSA (42% versus 21%; P < .01) and an increased risk of OSA on the Berlin Questionnaire (69% versus 43%; P < .01). Conclusions: Compared to trauma-exposed controls, Australian Vietnam veterans with PTSD demonstrated an increased prevalence of a wide range of sleep disturbances, including OSA. In veterans with PTSD, detailed sleep assessment, including consideration of polysomnography, is paramount